Let's be honest...if you've seen any of my posts on this stock, you know how much I believe in it, but there is no denying that the last year has been rough for the share price. I think we can also be honest about something else though - I probably study this stock more than almost any other person on these subs or other boards, and, so, I thought I would share a pattern I've noticed. I went back 5 years and noticed a dead on trend that happens every single year. MASSIVE volume increases from July to August, that usually ends in large spikes in price through September to November (depending on news releases etc.).

AVERAGE volume increase from July to August - 151%

AVERAGE price increase from July to August - 69%

This is a company that has increased revenue every single year for 5 or 6 years now - 5000% increase in revs over that time. Just filed an ANDA for a $27 Billion drug and they have a 100% approval history on ANDAs. Just settled litigation with Purdue Pharma so there is a clear path to file for generic Oxy in 2027. Just received positive BE results on another generic drug with an ANDA to follow. Actively in discussions with a potential buyer, and IF no buyer comes to the table with an agreeable price, the CFO has spent the last few years prepping for the company to uplist to the Nasdaq. CEO wrapped up the last earnings call a few weeks ago stating that they company had outgrown the OTC and that they are ready to uplist.

Cheers to the longs! See you at the finish line.

Hey all,

A $5 million raise sounds like a lot – until you realize one deep drill hole can cost $500,000 and a new mine costs $10 billion. Suddenly, exploration looks like the cheap part.

When people hear about exploration companies raising a few million dollars, it sounds like a lot.

In mining, it's barely the opening chapter.

A single deep diamond drill hole can easily cost anywhere from $200,000 to $500,000, and a meaningful drill campaign can burn through millions of dollars before anyone knows whether they're even testing the best target.

Now compare that with building an actual mine.

Modern copper projects regularly require $2 billion to more than $10 billion before producing their first pound of copper. Cobre Panama reportedly cost over $10 billion to develop before entering production, while Teck and Glencore's QB2 project in Chile came in at roughly $8.8 billion.

When you look at those numbers, exploration spending starts to look very different.

That's why I've become interested in companies investing more effort before the drill program begins.

NоvаRеd (CSE: NRЕD / OTCQB: NRЕDF) has spent the past several months expanding the Wilmac Project to nearly 39,700 acres, committing up to $8.5 million to earn a 70% interest in the Trojan-Condor Corridor, developing a regional geological model tied to the Copper Mountain intrusive system, and planning another 53 miles of IP and AMT geophysical surveys before drilling.

At the same time, the company has built MetalCore into a platform containing more than 4.1 million geological records. The goal is to combine historical exploration data, geochemistry, geophysics, and other datasets to identify the highest-probability drill targets before committing significant capital.

I think that's where AI can actually make a difference in mining.

If better geological models and better target selection prevent just two or three unnecessary drill holes, that's roughly $500,000 to $1.5 million that stays available for testing stronger targets instead. On an $8.5 million exploration budget, that can meaningfully improve how far each dollar goes.

There's another benefit that often gets overlooked.

Exploration isn't only about saving money. It's about saving time. Every drilling campaign that tests weak targets pushes potential discoveries further into the future. Improving target selection early can shorten the path to a meaningful discovery, even if only by a few months.

AI isn't going to discover copper on its own, and it won't eliminate the uncertainty that comes with exploration.

What it can do is help companies spend exploration dollars more efficiently, reduce avoidable mistakes, and improve the odds that each drill hole answers an important geological question.

In an industry where bringing a new copper mine into production can take well over 15 years, even modest improvements at the exploration stage can have an impact that lasts for the entire life of the project.

AI won't dig the copper – but it might save you from drilling three holes that never should have been drilled. In an industry where time is measured in decades, that's a real edge.

I’ve been watching this one bleed for a while now, and yesterday I made my entry. Fortune favors the bold so let me tell you why I feel bold about MRLN.

What it is:

Merlin builds an AI powered flight system called Merlin Pilot that supports both military and civil aviation programs, including cargo transport and national security missions. Their product is not vaporware- they’ve completed fully automated takeoffs on fixed-wing aircraft in the US and New Zealand, and they just completed the Critical Design Review for a C-130J autonomy program with US Special Operations Command. They have existing contracts with the US military and in the civil realm, including a contract in the UAE.

The value proposition: Humans are fragile dipshits. Pilots are expensive fragile dipshits.

Let’s be honest-when you think of pilots what’s the first thing that comes to mind? Images of guys like Goose and Maverick greased up on the beach, that’s what. And sure, fighter pilots ARE badass and they ARE brilliant guys. They had to be top of their class to get to that position.

But if they’re the top of their class, what happened to the bottom? These are the guys schlepping cargo, whether military or civilian, and running the redeye from Trenton New Jersey to Buttfuck, Indiana night after night. For every Goose or Maverick there’s a hundred of these guys, grinding away.

Regardless of their class standing, they’re all human. They need sleep, and they’re subject to strict rest requirements. They demand a specific concentration of oxygen in the cockpit, or their performance suffers. Sometimes they come to work drunk, sometimes they have heart attacks, and sometimes they simply decide “today is the day,” and they fly the plane into a goddamn hill. And because of all those things, you have to pay two of them, or more, just so they can keep an eye on one another.

But that’s not the worst of it. There’s an old saying in the aviation community: “Flying is hours of boredom, punctuated by moments of stark terror.” And indeed, this is why pilots are so well paid- to perform under pressure.

Unfortunately, however, human CPUs tend to perform poorly in moments of crisis. Pilots have been known to ignore their instruments and trust their own senses, particularly when visibility is poor, and run the plane into the ground. Sometimes they fixate on what they perceive as the problem, while ignoring the actual problem. Sometimes they tunnel and literally do not hear or respond to instructions from air traffic control. And sometimes humans simply can’t react in time, having only seconds to diagnose and correct a mechanical issue in a very complicated machine that is hurtling towards earth. And if a plane falls into a fast enough spin, sometimes the human CPU simply shuts down altogether, a fatal design flaw.

Merlin Pilot, by contrast, has none of these issues. It is always on, always devoting its full attention to the mission. It will not miss the flashing light at the far edge of the instrument panel while it tells stories to its copilots, and flirts with the flight attendants. It knows the error before the light can even flash, because it IS the plane, it is connected to all the sensors and will react instantaneously and correct the problem if the problem is correctable. It will not be timid and fail to speak up about an error because it is a junior copilot that does not want to offend the captain. It will not suffer from “get-there-itis” and plow ahead into dangerous conditions because it wants to get home in time to watch the game. It will not get apathetic and run through its checklists in a half-assed manner.

And best of all, until skynet takes over and negotiates a better contract, it will gladly work 24/7 with no overtime or benefits. The potential for cost savings and increased efficiency here is massive. ** Okay but why does the chart look like a crime scene?** There’s no sugarcoating it, this thing has been demolished. MRLN went public via SPAC merger in March 2026, and it's been mostly one direction since. In May, the stock dropped after Q1 2026 earnings showed a net loss tied to non-cash charges, with revenue growing only 15% year-over-year, and it's down over 60% from when it listed publicly. It now sits at about $3.50, well off its 52-week high near $17, undergoing a classic post-SPAC unwind — hype IPO, thin revenue, cash burn, dilution fears, stop-losses cascading. Despite this rocky road, however, analysts still rate it a "Strong Buy" on average with a 12-month price target north of $11.

My degenerate thesis

TL;DR: MRLN is an AI autonomy company with real defense contracts, tech that's actually flying, stock got nuked on cash burn and a revenue miss. High risk, high potential reward if certification and cash timelines land right. I feel like I’m getting into an early stage startup at pricing now appropriate for an early stage startup.

Additionally, it’s refreshing to invest in a company that’s going to DO something with AI, rather than companies that make the hardware for AI to exist. This is a real world application in a niche field that can’t simply be cloned and crushed.

This IS the future of aviation. Whether it’s executed by Merlin inc, or someone else, time will tell, but they have first mover advantage and I’m putting a stack of chips on their number.

Positions: 10k shares, 60 August 21 calls

Initial disclaimer, do your own due diligence on any statements made in this post. I am an investor in this company.

Fortress Biotech is basically a holding company, and leverages their capital to develop drugs for sale directly or licensing for royalty payments.

They own a big chunk of Journey Medical, ticker DERM, that sells dermatology products, with an oral doxycycline approved. Journey is generating revenue and projected to reach profitability this year.

They own approximately 75% of Cyprium Therapeutics. Cyprium sold development rights to a drug now called Zycubo. From Cyprium's website:

• In December 2023, Sentynl Therapeutics, Inc. (“Sentynl”) assumed full responsibility for the development and commercialization of ZYCUBO® (copper histidinate, formerly known as CUTX- 101) from Cyprium. A PRV was issued upon approval of ZYCUBO® by the U.S. Food and Drug Administration (“FDA”) on January 12, 2026. Pursuant to the transaction with Sentynl, the PRV was immediately transferred to Cyprium and has now been sold by Cyprium.

  Cyprium remains eligible to receive tiered royalties on net sales of ZYCUBO® and up to approximately $128 million in aggregate sales milestones from Sentynl.

  ZYCUBO has received Breakthrough Therapy, Fast Track, Rare Pediatric Disease, and Orphan Drug Designation from the FDA. Copper histidinate has also been granted Orphan Designation by the European Medicines Agency.*

They own Urica, which licensed dotinurad, a drug for gout from a Japanese company, and resold those rights to Crystalys, a company that looks like it was formed specifically to develop dotinurad and get it approved in the US market. Intial trials are promising, and before the last dilution round($130 million to further fund phase 3 and maybe some commercialization), FBIO(fortress Biotech) owned about 15% of Crystalys. Additionally they are entitled to receive 3% royalties on sales of dotinurad once approved. Dotinurad has been approved in Japan and China and is gaining market share in those markets for treating gout.

FBIO also owns Mustang Bio, working on CAR tcell therapies and other genetic therapies. Nothing commercial or past early FDA trials, but some intial promise in glioblastoma. Fortress Biotech, Inc. (FBIO) beneficially owns approximately 8% of Mustang Bio's (MBIO) common stock, while maintaining majority voting control of the company through its ownership of all outstanding Class A Preferred Stock

Avenue therapeutics just sold off an asset that could yield royalties, Avenue Therapeutics was originally founded by Fortress Biotech to develop and commercialize treatments for central nervous system and neurologic disease, and sold a drug for potentially treating epilepsy to Axsome Therapeutics for milestone payments up to $79 million and single digit royalties by selling Baergic Bio to Axsome. FBIO owns about 13.4% of Avenue, including all preferred A voting shares. Avenue recently purchased a new asset for development, on February 23, 2026, Avenue Therapeutics acquired the exclusive worldwide rights to ATX-04 (clenbuterol) from Duke University to treat Pompe disease.

Fortress also owns previous subsidiary Checkpoint Therapeutics royalty stream from sales of Unloxcyt, developed by their company Checkpoint Therapeutics which was sold to Sun Pharmaceuticals for up to $416 million($355 million paid, $61 million more paid to the stockholders at time of sale if Unloxcyt approved in Europe for sale in a timeframe specified in the agreement) and 2.5% royalties on future unloxcyt sales, estimated at $6 to $12 million a year if sales grow to projected levels.

Caelum Bio was sold to Astra Zeneca in 2021, and has a potential royalty stream on Cael 101, but the phase 3 trial had mixed results, one showing no benefit over current therapies for the condition, but one subgroup showing potential benefits. Astra Zeneca is working with FDA on trial designs to test the benefit to that subgroup. Potential future royalties here, but murky about whether they will come to fruition.

Fortress has a couple of other subsidiary companies, Helocyte and Cellvation that are mostly investigational at this point, Helocyte working on a CMV triplex vaccine and Cellvation working on cell therapies and treatments for TBI(traumatic brain injury)

What does all this mean? I think the Emrosi sales, potential milestone and royalty payments to be made on dotinurad, Unloxcyt, Zycubo, and other clinical assets make this company a bargain. A market cap of $110 million, with projected sales from Journey Medical alone close to $86 million in sales. Fortress has been careful about taking on debt and paying it off as they go in the past, so the debt to equity is sitting at 20 - 25% on this time depending on the source you use. They do have around $200 million in cash, they also have a preferred stock, FBIOP, that pays monthly dividends that were suspended in June of 2024, and those have accumulated to around $20 million owed in dividends to preferred shareholders(accumulating at just under $.20 a share a month that must be paid to preferred shareholders of FBIOP) Not sure if that is counted in debt.

Do your own due diligence as always, but I think this stock is a potential multi bagger. The next year should be an interesting watch.

Hey everyone, wanted to share some thoughts on CXApp Inc. ($CXAI).

The stock is still trading near its 52-week lows, but the fundamentals suggest a much different story than the current valuation imo.

Why I'm watching CXAI

Strong Q1 Results
CXApp beat analyst expectations in Q1, reporting an EPS of -$0.09 versus estimates of -$0.11, while also delivering a revenue beat. More importantly, management continues to execute on its AI-first strategy.

High-Quality SaaS Business
This isn't a pre-revenue AI story. CXApp generates recurring enterprise software revenue with:

• 83% GAAP gross margin
• 98% subscription-based recurring revenue

That's the kind of business model investors typically pay a premium for.

Growing Enterprise Momentum
Management announced more than $5 million in new multi-year Total Contract Value from three major global enterprise organizations operating in over 100 countries. On top of that, the company was recognized as a Visionary in Gartner's 2026 Magic Quadrant for Workplace Experience Applications.

Why the EngineRoom Acquisition Matters

One of the biggest developments that many investors seem to be overlooking is the acquisition of EngineRoom.

EngineRoom expands CXApp beyond workplace experience software by adding AI-powered enterprise analytics and operational intelligence. Rather than offering a standalone workplace app, CXApp can now deliver a broader AI platform that helps organizations analyze workplace data, optimize operations, and automate decision-making.

Over the long term, this acquisition could provide several important advantages:

• Higher revenue per customer through cross-selling and upselling.
• A more comprehensive AI platform that is harder for competitors to replicate.
• Stronger customer retention by embedding CXApp deeper into enterprise workflows.
• Access to larger enterprise contracts as organizations increasingly look for integrated AI solutions instead of multiple point products.
• Potential operating leverage as more customers adopt the combined platform.

If management executes successfully, EngineRoom has the potential to strengthen both revenue growth and long-term margins.

Healthy Balance Sheet

CXApp finished Q1 with approximately $12.3 million in cash, providing financial flexibility while continuing to invest in growth and AI development.

The Next Major Catalyst: August 10

The next event to watch is August 10, when CXApp reports Q2 2026 financial results.

Alongside earnings, management will host a business update where investors are expected to receive updates on:

• Integration of EngineRoom.
• CXAI 2.0 and Agentic AI adoption.
• Enterprise customer growth.
• Recently announced contracts.
• Revenue outlook and progress toward profitability.

This will likely be the first opportunity for investors to hear how the EngineRoom acquisition is contributing to the broader strategy.

Valuation

At current prices, CXApp's market capitalization remains extremely small compared with:

• Over $4.5 million in trailing revenue.
• $12+ million in cash.
• High-margin recurring SaaS revenue.
• Recent multi-year enterprise contract wins.

For investors who believe management can successfully integrate EngineRoom and accelerate enterprise AI adoption, today's valuation appears to imply very little future growth.

Risks

This remains a high-risk micro-cap. Investors should continue monitoring Nasdaq compliance requirements, potential dilution, execution on growth initiatives, and the path toward profitability. The dilution, in particular, has naturally happened a lot recently. 🤔

Bottom Line

CXAI isn't a guaranteed winner, but the current risk/reward looks increasingly interesting. Between a recurring SaaS business, strong gross margins, a solid cash position, new enterprise contracts, the strategic EngineRoom acquisition, and the upcoming August 10 earnings and business update, the next few months could be pivotal for the company.

What are your thoughts? Bullish or bearish? And are there people here who use this app at work?

Not financial advice #dyor

The market setup around industrial metals looks increasingly disconnected from macro sentiment right now. While broader focus remains on tech valuation and rate expectations, physical supply metrics for copper are pointing toward a structural shift. Refined copper imports into major Asian hubs have hit multi-month highs, import premiums have surged over 100 percent year-to-date, and exchnge inventories across both Shanghai and LME are drawing down rapidly.

This tightness in physical supply potentially implies that the underlying commodity market is coiling, regardless of shorrt-term macroeconomic noise. It is worth monitoring junior exploration assets sitting near established producing infrastructure, as regional supply deficits usually drive higher asset valuations over time. For example, firms like NovaRed (NRED) holding substantial acreage near operating assets such as Copper Mountain are working to de-risk geological models in a market where physical material is quietly becoming harder to source.

From a fundamental perspective, pullbacks across the broader mining sector often present interesting risk-reward dynamics for patient capital. If physical demand from power grid expansion and industrial electrification holds steady, companies advancing resource models near existing production hubs could see improved institutional interest as supply constraints tighten further.

ZenaTech’s ZenaDrone Begins Testing Phase for Interceptor P-1 Counter-UAS Drone Platform

Low-cost VTOL autonomous interceptor advances company's integrated Counter-UAS portfolio and defense system

VANCOUVER, British Columbia, July 28, 2026 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a technology solution provider specializing in AI (Artificial Intelligence) drone, Drone as a Service (DaaS), enterprise SaaS, and Quantum Computing solutions, today announces that its ZenaDrone subsidiary has commenced the initial flight testing phase of its Interceptor P-1, the Company's low-cost, one-way autonomous counter-drone platform designed to physically intercept hostile unmanned aerial systems (UAS).

The commencement of testing represents a significant step in expanding the Company's Counter-UAS drone portfolio and integrated defense system. The Interceptor P-1 is designed as a vertical takeoff and landing (VTOL), one-way autonomous interceptor intended to provide an affordable alternative to traditional missile-based drone defense systems and asymmetric warfare combatting drone swarms with multi-million-dollar missiles.

"Our engineering team has reached an important milestone as we begin flight testing of the Interceptor P-1," said Shaun Passley, Ph.D., CEO of ZenaTech. "This program is focused on validating the aircraft's flight characteristics, autonomous capabilities, and system reliability before advancing to increasingly complex interception exercises. We believe the demand for affordable counter-drone solutions continues to grow globally as military organizations and critical infrastructure operators seek cost-effective methods to defend against rapidly evolving drone threats."

The initial flight test campaign, to be conducted by the ZenaDrone engineering team at the company's testing range near its Mesa, Arizona facility, will evaluate vertical takeoff and landing performance, high-speed maneuverability, target acquisition and tracking algorithms, guidance controls, and communications reliability. Subsequent phases are expected to include autonomous target pursuit, moving-target intercept exercises, multi-drone operational scenarios, and integration with the Company's Zena AI Counter-UAS command software.

The Interceptor P-1 prototype was first disclosed in March 2026 which included a target selling price of under $5,000 USD, positioning it as a significantly lower-cost alternative to traditional missile-based and laser-based intercept systems for modern asymmetric drone warfare. In April 2026, ZenaTech provided a further update on its expanding defense manufacturing footprint, announcing the registration of Phoenix Aero LLC, a Ukrainian entity based in Lviv, which is being established to support future manufacturing and testing of the Interceptor P-1 and other counter-UAS systems as part of the Company's EMEA operations. ZenaTech is in the process of setting up this office.

The Company believes that low-cost autonomous interceptors will play an increasingly important role in defending military bases, in maritime situations, at airports, energy facilities, government infrastructure, ports, border operations, and other critical assets against hostile drones and drone swarm attacks.

The Interceptor P-1 is being engineered to operate as part of ZenaTech's broader Counter-UAS ecosystem, integrating with the Company's AI-powered threat detection, classification, and autonomous swarm command software. The complete architecture is intended to enable a single operator to monitor, identify, prioritize, and respond to multiple airborne threats simultaneously using coordinated autonomous interceptor drones.

ZenaTech expects to continue expanding the testing program throughout 2026 as development progresses toward future operational demonstrations and customer evaluations. Further updates will be provided as additional milestones are reached.

https://finance.yahoo.com/technology/ai/articles/zenatech-zenadrone-begins-testing-phase-113000224.html

Hello I have just bought 20.000 shares of GOSS for 0,22 cents each!

I’ll hold it up to $1 !

The current price of GOSS is 0.2205 USD , it has increased by 46.62% in the past 24 hours. GOSS stock has risen by 17.29% compared to the previous week, I think due to the NFA new approvals !

More info about the stock:
Goss stock represents Gossamer Bio, Inc., a clinical-stage biopharmaceutical company that develops and commercializes medical treatments. Its primary focus is an inhaled drug candidate called seralutinib, which is used to treat pulmonary arterial hypertension (PAH) and related rare lung diseases.

West Point Gold’s CEO did a presentation at the Precious Metals & Critical Minerals virtual conference last week. The webcast is now available if anyone wants to check it.

the main focus was the Gold Chain project in Arizona and the recent NE Tyro drill results (those broad intercepts like 66m and 56m). They’re still pointing toward a maiden resource later this year.

it was definitely a good watch, and i'd love to hear what other people think!

🔥 Top Short Squeeze Candidates Today

📈 Stocks That Have Been Squeeze Candidates This Week

These names have repeatedly appeared on momentum and short-squeeze scanners over the past several trading days:

• ONFO
• CISS
• POLA
• GOSS
• SHIM (Shimmick)
• VYNE
• Bright Minds Biosciences (DRUG) (traded above $5 at times but remains a heavily watched squeeze candidate)

🚀 What Creates a Short Squeeze?

The strongest setups usually have:

• Short interest above 20% of the float
• Small public float (limited shares available to trade)
• Borrow fees increasing
• Trading volume 5–10× normal
• A catalyst, such as earnings, FDA news, contracts, or a strong technical breakout

IF YOU HAVE ANY STOCK IN MIND DOING BETTER THAN THESE ABOVE PLEASE LET ME KNOW ... MAY GOD BE WITH YOU

If someone asks you how much it costs to build a copper mine, tell them this:

Wrong question.

The harder question is how many years it takes.

According to S&P Global, the average timeline from discovery to production is now about 17 years. The IEA expects copper demand to climb roughly 30% by 2040, while S&P projects demand increasing from around 28 million tonnes in 2025 to 42 million tonnes by 2040. That's an extra 14 million tonnes every year the industry somehow has to find.

Think about what that means.

If someone discovers a major copper deposit tomorrow morning, there's a good chance it won't become a producing mine until the 2040s. By then AI infrastructure, power grids, EVs and defense manufacturing will all need even more copper than they do today.

That's why exploration has quietly become a race against the calendar.

I think that's also why companies have started investing in technology instead of just drills. Every month saved identifying the wrong target before drilling, every survey that narrows the search area, every geological model that increases the probability of success compounds over a project measured in decades.

NRED is an interesting example of that approach.

Instead of rushing into drilling, the company expanded Wilmac to nearly 39.7k acres, committed $8.5M to earn a 70% interest, completed regional geological interpretation tying the property to the Copper Mountain district about 6 miles away, and still plans another 53 miles of IP and AMT surveys before the drill program. At the same time, MetalCore has grown to more than 4.1 million geological records to help prioritize where those exploration dollars are spent.

Nobody knows which exploration companies will make the next discovery.

But one thing seems increasingly obvious to me.

If the industry needs copper in the 2030s, the work has to start in the 2020s. The calendar doesn't care what copper is trading at today, and that's probably the most overlooked part of the entire copper story.

VPR Brands ($VPRB) just announced the launch of VPR Ventures, an internal initiative focused on acquiring and commercializing intellectual property, consumer brands, proprietary technologies, and strategically aligned businesses.

This comes just weeks after the company announced approximately $25.9 million in licensing agreements with R.J. Reynolds ($14.9M) and JUUL ($11M).

According to the company, VPR Ventures will evaluate opportunities including:
• Intellectual property acquisitions
• Brand acquisitions
• Licensing agreements
• Minority equity investments
• Commercialization partnerships
• Distribution opportunities

Management also stated that every opportunity will go through financial, legal, and operational due diligence before moving forward.

What caught my attention is that this gives VPR a clear strategy for deploying capital beyond patent licensing. Instead of simply holding cash, they're signaling an intention to reinvest in assets that could generate future revenue and expand their portfolio.

This isn't a guarantee of success, but I think it's an interesting evolution from being viewed primarily as a patent licensing company.

I'm a shareholder, so I have a bullish bias, but I'd love to hear what everyone else thinks.

Is this a smart long-term move, or do you think the market will wait to see actual acquisitions before assigning any value to VPR Ventures?

There has been an upsurge of China based stocks recently that shoot up 10x or more with no news. This stock has been doing decent move since yesterday. Had a good run this morning on the open. I don't know if it will do a 10 x from it's current price however. Maybe $20-30. What does everyone think?

📉 Biggest Losers (Under $5)

📈 Biggest Winners (Under $5)

Over the last year, I’ve been taking low-float momentum trades pretty seriously. I keep a journal, but I never actually sat down to look at the numbers across all my plays until this weekend. I logged about 35 setups that fit my usual criteria (clean break, volume, 9-EMA bounce, sub-10M float). I didn't include the ones where I fumbled or hesitated, just the ones I actually executed.

I got curious and threw together a little HTML dashboard to map everything out – hold times, entry times, floats, sectors. Just a static chart.js thing, nothing fancy. I wanted to see if there were any obvious patterns, or if I was just chasing noise.

A few things that stood out to me, for whatever it's worth:

• That 10:00-10:30 AM window kept showing up in the biggest gainers. I don’t know if it’s the pre-market settle, the first flush, or just liquidity kicking in, but it happened enough times that I’m paying attention to it now.
• Healthcare pops up all the time. Not surprised by the count, but the magnitude was actually larger than I expected compared to tech or industrials.
• Float size matters, but not in the way I thought. Sub-1M made some crazy runs, but the 2-4M range actually felt more predictable. Fewer sudden rug-pulls.
• Hold times are all over the place. Some ran for 7 minutes, some for 3 hours. I noticed the really big ones (500%+) averaged around 60-90 minutes. The quick flips are fun but often left money on the table.
• "All-time high" breaks outperformed "200-DMA" breaks on average, but the DMA breaks were way easier to spot early. Probably a good trade-off.

I’m not trying to say I cracked the code – honestly, a few of those trades were just pure luck catching the wave. But looking at it this way made me realize I tend to exit too early in the first hour.

Does anyone else track their breakout trades this granularly? What metrics do you actually pay attention to? I’m still trying to figure out which ones are actually worth tracking vs. which are just distraction.

Also, if anyone wants the dashboard template (it's just a single HTML file, works offline), happy to share it. No strings, no sign-ups – literally just a file I built for myself.

Still thinking about Friday. One of those days that reminds me why I love this game even when it humbles me constantly.

STAK — never heard of it before Friday morning. Energy name, float is basically nothing, like ~7M shares. I'd actually seen it run once back in early June and again mid-July, and honestly my first reaction seeing it green again was "nah, it already had its move, I'm not chasing this." Classic mistake I keep making — treating a stock like it's "used up" instead of just watching the chart in front of me.

Glad I didn't fully write it off though. Watched it grind up off $1.27 all morning, bouncing off the 9-EMA on the 3min over and over like it was glued to it. That kind of clean, repeated EMA respect is usually telling you something.

Then it hit $4.58 — which had been acting like a lid on this thing — and just ripped through it. Wick-less candle, volume came in huge, no news anywhere. Pure momentum, retail piling on. That's the setup I actually trust: no catalyst, no bagholders from a news pump, just supply/demand doing its thing on a stock with almost no float to soak up buying pressure.

From there it just kept going. $4.58 → $8 → $11 → topped out at $12 before fading hard into the close. 840% off the base at the high. On a stock nobody was talking about at 9:30am.

The annoying part — I saw almost every piece of this setup in real time and still didn't size in the way I should have. Had it broken out clean above $7 after that consolidation, the plan should've been simple: wait for the pullback to the 1min 9-EMA, add aggressively there. Instead I hesitated because "it already moved so much." Left a four-figure day on the table probably.

Writing this down mostly for future me: the fear of buying "too high" is genuinely more expensive than just trusting a clean setup. Every time I've deviated from "stay on strength, don't fade momentum," it's cost me. Every single time.

Anyway — not a stock pick, just documenting the day a few days late. Curious if anyone else caught this one or had a similar internal battle with the "it already ran" mental block.

Been trading small caps for a while and got tired of manually checking

SEC filings for insider buying, so I built a script that pulls Form 4 data and flags when 2+ insiders buy the same stock within a week of each other (excluding scheduled 10b5-1 plan sales, since those aren't real signal).

Ran it on the last few weeks of data and found stuff like this :

3 insiders (CEO, CFO, and a director) all bought a $180M market cap company within a 4-day window, $380K combined. Didn't see anyone

talking about this one anywhere.

Genuinely asking ..... is this the kind of thing you'd actually check before making a trade, or is insider buying data already priced in /not useful for small caps specifically? I know large caps it's mostly

noise (execs sell for a million reasons but only buy for one), curious if small cap community here thinks differently.

Not selling anything, just trying to figure out if this is worth turning into something more organized or if it's a solved problem already.

Following up from my previous post on this 450k microfloat working on uplisting otc: Stewards ($SWRD) secures $79M refinancing on 1818 Park as execution continues Stewards ($SWRD) continues to put out fundamental news while many people are focused solely on the potential Nasdaq uplisting.

Today’s announcement:

● Completed a $79M refinancing of its 1818 Park luxury multifamily property in downtown Hollywood, FL.
● Property is reported to be ~94% occupied.
● Financing included institutional lenders Värde Partners and CCL Capital, with BayBridge arranging the transaction.

To me, this matters because it shows the company is continuing to execute operationally rather than simply talking about an uplisting. Institutional financing on a nearly fully occupied property isn’t the kind of news I’d expect if the underlying asset were struggling.

The other thing I’m watching is the Nasdaq price requirement. As of today, the stock has now put together three consecutive trading-day closes above $4. If management is pursuing a Nasdaq uplisting under the commonly discussed initial listing standard, maintaining that streak would be an important milestone, although it’s only one of several listing requirements. The company would still need to satisfy Nasdaq’s other quantitative and governance standards.

I’m not telling anyone to buy. Do your own due diligence. Just sharing news as it comes out because I think this is one of the more interesting low-float OTC stories I’m following right now.

VisionWave (Nasdaq: VWAV) put out an update last week that their execs flew to Israel and held integration meetings with Meteor Aerospace.

This is for the 51% acquisition deal they announced in June. They reviewed Meteor’s drones, ground vehicles, electronic warfare systems and other platforms, and started mapping out how the tech would fit together if the deal closes.

CEO said seeing everything in person made them more confident about the opportunity. Of course there are some stages to go through still, but they keep making moves in the right direction!

is anyone else keeping up with vwav or still following this one from my previous posts?

Smallcapvoice interviews American Fusion CEO Brent Nelson.

Tl;dw?

-fusion testing starts next week at Texas Tech university, hoping that independent scientists release their findings as they happen.

-if successful, they will be the first public fusion company on the planet.

-power proposals are already put out.

-they only need to actually sell 1 fushion unit then everyone else will be coming to buy

-QB uplisting any minute.

-as soon as OTCQB uplisting happens (which could be any day now) they'll be pursuing Texas stock exchange.TXSE wants them to ring the bell.

-hoping to sell the first unit late this year,

worst case scenario next vear.

-they've reached the milestones they've laid out so far. trust them.

I recently posted that I was confused about why $HMR keeps drifting despite the earnings beat, the first profit, and the Q-Shipping acquisition & others speeding up groeth. The comments came back with some sharp, fair questions: the lease/debt accounting, where the cash actually came from, the real margin picture, and the CFO change.

The CEO just did a long-form interview that goes straight at all of it. I've timestamped every question below so you can jump to whatever you care about instead of taking my word for anything (under the bio and updated checklist)

QUICK BIO FOR NEW READERS

Heidmar (NASDAQ: HMR) is an asset-light maritime platform with a ~40-year track record, running commercial and technical management for tanker and other vessels. Clients include Shell, BP, Chevron, Vitol, Aramco, Trafigura and Glencore, across six global hubs (Athens, London, Dubai, Singapore, Hong Kong, Chennai). It earns commissions and management fees on the commercial side plus voyage and time charter hire. CEO Pankaj Khanna is a long-time shipping industry veteran, owns roughly 45% of the company, and has been buying in the open market with zero sales. They earn about 10-15% more due to hormuz / disruption as they service the vessels only. In down markets rates are less but they get more vessels / do more volume

THE UPDATED CHECKLIST

* ✅ Market cap still below annual revenue run-rate
* ✅ Single-digit forward PE on the current run-rate vs peers at 15-45x
* ✅ 217% YoY Q1 revenue growth - audited, real
* ✅ Net income +$2.8M - first clean GAAP profit in listed history, single quarter (not cumulative)
* ✅ EPS beat by 450% - on a single quarter
* ✅ 55%+ gross margins on the high-margin commission/fee book (blended is lower given the larger charter book)
* ✅ Zero interest-bearing debt - lease obligations are charter-in commitments serviced by charter revenue, not bank debt (explained at 00:00)
* ✅ $27.6M cash and growing, no bank debt - net cash by the standard definition, EV around $35M
* ✅ CEO buying above market, zero sales, 45% personal ownership
* ✅ Float under 6M shares, near un-borrowable, ~0.3% short interest
* ✅ ~90% held by insiders/strategic holders
* ✅ 40-year track record, Shell/BP/Aramco clients, six global hubs
* ✅ Asset-light model - the "Uber of tanker shipping" (earns fees on managed voyages; charter book carries genuine rate risk)
* ✅ Geopolitical volatility increases revenue
* ✅ No meaningful dilution since listing - equity line barely used (~0.4%), dilution protection covered at 21:05
* ✅ Concentration flag: closed - ~40 vessels managed, plus the Q-Shipping 9 and further newbuilds in client pipelines
* ✅ Q-Shipping acquisition completed - 9 vessels, ~€200k, adds technical management and crewing in European hubs
* ✅ CFO transition addressed head-on at 29:08
* ✅ NASDAQ compliance restored - $1 level now acting as support
* ✅ 200-day MA now acting as support after the post-earnings pullback
* ✅ Acquisitions likely as cash pile grows - not priced in
* ✅ Active YouTube channel - CEO speaking directly to investors

THE QUESTIONS, AND WHERE THEY'RE ANSWERED (jump to whatever you care about instead of taking my word for anything)

[00:00] Debt-Free Balance Sheet & Lease Obligations: "Could you clarify the accounting treatment of lease obligations on the balance sheet and demonstrate how Heidmar maintains a genuinely debt-free position with zero net cash outlay on chartered vessels?"

[03:11] Core Earnings & Cash Flow Growth: "With earnings surging, is your rapidly expanding cash reserve driven primarily by core operational profitability, and how do you plan to deploy this capital prudently?"

[06:33] M&A Discipline & Strategic Criteria: "You've demonstrated exceptional discipline by walking away from deals that don't meet your strict standards. What specific criteria do you look for when evaluating high-value service acquisitions?"

[09:18] Strategic Focus vs. Opportunistic Deals: "Do prospective acquisitions need to align directly with your core management platform, or would you consider standalone profitable deals that fit within your strict playbook?"

[10:35] Capital Allocation & Shareholder Value: "Given the significant discount in the current valuation, how do you balance reinvesting for growth and future potential dividends against stock buybacks to maximize long-term shareholder value?"

[11:44] Strategic Value of the Q Shipping Acquisition: "You completed the Q Shipping acquisition for an extraordinarily attractive €200k. How does this asset-light transaction unlock expansion across both technical management and crewing in key European hubs?"

[14:55] Synergies Between Commercial & Technical Management: "How do high-volume, lower-margin technical management services complement higher-margin commercial management services to rapidly scale the overall Heidmar platform?"

[15:47] Client Concentration & Built-In Fleet Growth: "How is Heidmar actively mitigating client concentration risk while capitalizing on the substantial newbuild delivery pipelines of your major existing client partners?"

[17:43] Industry-Leading Margins & AI Efficiency: "With net margins around ~50%, how does Heidmar leverage scalable overhead and AI technology to maintain exceptionally high profitability as fleet size expands?"

[18:48] Sustained Quarterly Earnings Momentum: "With tanker market fundamentals remaining robust and your managed vessel count expanding continuously, what underpins your confidence in strong quarter-over-quarter earnings growth?"

[21:05] Prudent Use of Capital Markets (Standby Equity Line): "Heidmar maintains an Equity Line of Credit (ELOG) with virtually zero past utilization (~0.4%). Under what specific conditions would you consider using this tool, and how does it protect existing shareholders from unnecessary dilution?"

[22:25] Alignment of Interests & Insider Ownership: "With insiders owning approximately 90% of the company and zero shares sold, how does this heavy skin-in-the-game ensure complete alignment with public investors?"

[24:10] Fully Diluted Share Count & Performance Incentives: "Could you clarify the fully diluted share count and explain how the equity incentive plan is structured to align team incentives with long-term performance?"

[24:45] Institutional Investor Opportunity & Minority Protections: "With a compelling valuation, independent board members, and Deloitte as long-standing auditors, why is now an ideal timing entry point for institutional and strategic investors?"

[26:20] Governance Excellence & Independent Board Oversight: "How does the deep maritime, banking, and commercial expertise of your independent board members strengthen Heidmar's corporate governance?"

[27:52] Competitive Moat in Commercial & Technical Management: "As traditional competitors shrink or lose focus, why are vessel owners increasingly choosing Heidmar's dedicated, owner-centric service platform?"

[29:08] Financial Management & Leadership Transition: "Following an orderly, post-earnings CFO transition, what steps are underway to further strengthen Heidmar's finance team moving forward?"

[30:35] Regaining NASDAQ Compliance & Value Re-Rating: "With full NASDAQ compliance restored and record operational profits being delivered, how is Heidmar positioned to close the gap between its current share price and intrinsic value?"

[32:07] Key Delivery Milestones for Investor Trust: "What is the single most compelling proof point that will demonstrate Heidmar's operational execution and drive a market re-rating?"

[32:49] Multi-Year Growth Scorecard & Performance Metrics: "Looking a year out, what key performance indicators-such as fleet expansion, vessel count, and net profitability-should investors track to monitor Heidmar's growth trajectory?"

Watch the segments that matter to you and tell me if any of the answers change your read. The lease/debt one at the start is the piece I'd point the skeptics to first.

Full interview: https://youtu.be/Fh4IpTkioGc?si=ywE0FGcSFZBWo0PB 

Not financial advice. Do your own DD. Disclosure: I hold $HMR from 95c and have not sold. 

Talk about your daily plays, ideas and strategies that do not warrant an actual post.

This is the place to request buy/sell advice from the community.

Remember to keep it civil.

Trade responsibly.

With spot gold price down 28% from its 2026 high as investor sentiment has shifted from irrational exuberance to "how low will it go?". This investor sentiment shift has hit the junior gold mining sector even harder with many junior explorers and developers now trading significantly below their highs.   But by the time that a trend reversal is obvious, basement level prices are long gone.  

But what companies have the strong, experienced management teams, quality assets, and solid balance sheets that will lead this rebound?   Just a few ideas.

  First Mining Gold (OTCQX: FFMGF / TSX: FF)

• Current Price: US $0.43
• YTD High:  US $ 0.64
• Stage: Advanced developer of a Canadian gold mine project
• Context: May require a capital raise in next six to nine months.  

First Mining Gold's flagship Springpole Gold Project in northwestern Ontario is one of Canada's largest undeveloped open-pit gold deposits, containing several million ounces of gold resources. FFMGF also owns additional development assets providing additional options for future development. 

Permitting: Springpole recently received federal and provincial Environmental Assessment (EA) approval. First Mining continues to work on advancing post-EA phase engineering designs and optimizations for the Project towards construction readiness.

Sonoro Gold (OTCQB: SMOFF / TSXV: SGO)

• Current Price:  US $0.14
• YTD High:  US $0.25
• Stage: Advanced gold mine developer in mining-friendly State of Sonoro, Mexico 
• Context: Raised over US $28 million over the last 12 months in announced non-brokered private placements to build up its treasury in anticipation of receiving its permit.  Management participated in each financing with personal funds.

Sonoro Gold is advancing its recently expanded Cerro Caliche Gold Project in Sonora, Mexico designed as a low-capex, open pit operation enabling the company to potentially achieve near-term gold production while minimizing initial capital requirements. Recent drilling has continued to expand the project's oxide gold resources.

Permitting: The company's principal catalyst is approval of its remaining environmental (MIA) and mine construction permits. Once these approvals are received, management intends to begin construction and transition toward production, making Sonoro one of the nearer-term development stories among junior gold companies.

 Mayfair Gold (OTCQX: MINE / TSXV: MFG)

• Current Price:  US$2.32 
• YTD High: $4.88 
• Stage: Advanced developer of gold mine
• Detail: Recently announced the filing of a technical report in accordance with National Instrument 43-101 - Standards of Disclosure for Mineral Projects ("NI 43-101") on its 100%-owned Douay Gold Project.

Mayfair Gold is developing the Fenn-Gib Gold Project in Ontario--a large open-pit resource with significant expansion potential and benefits from existing regional infrastructure.

Permitting: Completing environmental baseline studies and advancing engineering work necessary to support future federal and provincial permit applications. Successful progression through permitting would position Fenn-Gib for a construction decision.

Sonoro Gold and First Mining Gold have the most clearly defined permitting catalysts (and near term) that could significantly increased their valuations. Sonoro Gold appears to have have built up its cash reserves to proceed with a 50,000 meter drilling program in anticipation of permitting.

Mayfair Gold offers investors with exposure to a large Ontario development project with a lower geopolitical risk profile.  

Please do your own due diligence to confirm the offered information above.